Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
55M
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-12.5M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$16.3M
-
Number of sells
-
-56
Significant Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q3 2025
57 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q3 2025.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 55M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include CWM, LLC (0 shares), Trium Capital LLP (0 shares), PEDDOCK CAPITAL ADVISORS, LLC (0 shares), True Wealth Design, LLC (0 shares), NISA INVESTMENT ADVISORS, LLC (0 shares), STRS OHIO (0 shares), Y-Intercept (Hong Kong) Ltd (0 shares), Vanguard Personalized Indexing Management, LLC (0 shares), CITIGROUP INC (0 shares), and ZWJ INVESTMENT COUNSEL INC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.